Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
3.790
+0.150 (4.12%)
At close: Jul 10, 2026, 4:00 PM EDT
3.740
-0.050 (-1.32%)
After-hours: Jul 10, 2026, 5:13 PM EDT
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $19.63 million as of July 10, 2026.
Market Cap
19.63M
Enterprise Value
12.83M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.79
Market Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $19.63M, a decrease of -50.22%. That is a compound annual growth rate of -68.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 19.63M | -43.77% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daxor | 58.91M |
| Precision Optics Corporation | 54.18M |
| Nephros | 38.00M |
| Milestone Scientific | 31.27M |
| Harvard Bioscience | 28.10M |
| Retractable Technologies | 20.86M |
| Cuprina Holdings (Cayman) Limited | 14.18M |
| Jin Medical International | 14.17M |